Home Cart 0 Sign in  
X

[ CAS No. 40805-79-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 40805-79-6
Chemical Structure| 40805-79-6
Chemical Structure| 40805-79-6
Structure of 40805-79-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 40805-79-6 ]

Related Doc. of [ 40805-79-6 ]

Alternatived Products of [ 40805-79-6 ]

Product Details of [ 40805-79-6 ]

CAS No. :40805-79-6 MDL No. :MFCD00235052
Formula : C5H3N3 Boiling Point : -
Linear Structure Formula :- InChI Key :XVIAPHVAGFEFFN-UHFFFAOYSA-N
M.W : 105.10 Pubchem ID :10197646
Synonyms :

Calculated chemistry of [ 40805-79-6 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 26.75
TPSA : 49.57 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.96
Log Po/w (XLOGP3) : -0.5
Log Po/w (WLOGP) : 0.35
Log Po/w (MLOGP) : -1.08
Log Po/w (SILICOS-IT) : 0.92
Consensus Log Po/w : 0.13

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.73
Solubility : 19.5 mg/ml ; 0.186 mol/l
Class : Very soluble
Log S (Ali) : -0.07
Solubility : 88.8 mg/ml ; 0.845 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.67
Solubility : 2.26 mg/ml ; 0.0215 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.18

Safety of [ 40805-79-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 40805-79-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 40805-79-6 ]
  • Downstream synthetic route of [ 40805-79-6 ]

[ 40805-79-6 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 40929-49-5 ]
  • [ 40805-79-6 ]
YieldReaction ConditionsOperation in experiment
78%
Stage #1: With triethylamine; trifluoroacetic anhydride In dichloromethane at 0 - 20℃;
Stage #2: With sodium hydroxide In dichloromethane; water
Pyrimidine-5-carbonitrile (SO3-067): To a suspension of pyrimidine-5-carboxamide (SOS- OSS) (262 mg, 2.12 mmol) and triethyl amine (481 mg, 4.24 mmol) in anhydrous dichoromethane (15 ml) was slowly added a solutionf of trifuoroacetic anhydride (0.36 ml in 4 ml dichloromethane) at 0°C. The reaction mixture was stirred at 0°C to RT for 2 h. and quenched with water (2ml) and washed with NaOH (1 N, 5 ml) and brine (2 x 5 ml). Organic solvent was dried (MgS04) and evaporated at less than 30°C to provide SO3-067 as a pale yellow solid. (1 74 mg, 78percent). 1 H NM R (400 M Hz, DMSO) δ 9.44 (s, 1 H), 9.31 (s, 2H).
Reference: [1] Patent: WO2012/129564, 2012, A2, . Location in patent: Page/Page column 79
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 10, p. 3783 - 3805
[3] Journal of Organic Chemistry, 2015, vol. 80, # 5, p. 2676 - 2699
[4] Patent: WO2009/148452, 2009, A1, . Location in patent: Page/Page column 71
  • 2
  • [ 4595-59-9 ]
  • [ 40805-79-6 ]
YieldReaction ConditionsOperation in experiment
95% With 1-Butylimidazole In toluene at 160℃; for 16 h; In an autoclave, 1 equiv. of aryl halide or heteroaryl halide, 2 equiv. of 1-alkylimidazole, 0.1 equiv. of CuI, 0.2 equiv. of dried K4[Fe(CN)6] (potassium hexacyanoferrate(II)), tetradecane as an internal standard for the GC analysis and a suitable amount of toluene were combined under argon and heated to 160 C. (The K4[Fe(CN)6] was dried by heating powdered K4[Fe(CN)6]x3H2O in a vacuum of 1 mbar to 80 C. for at least 24 hours.) After 16 hours, the reaction mixture was cooled to room temperature. Conversion and yield were determinable by means of gas chromatography. An isolation of the product took place according to the customary workup (distillation, crystallization or chromatography).
82% With 1-methyl-1H-imidazole In toluene at 160℃; for 16 h; In an autoclave, 1 equiv. of aryl halide or heteroaryl halide, 2 equiv. of 1-alkylimidazole, 0.1 equiv. of CuI, 0.2 equiv. of dried K4[Fe(CN)6] (potassium hexacyanoferrate(II)), tetradecane as an internal standard for the GC analysis and a suitable amount of toluene were combined under argon and heated to 160 C. (The K4[Fe(CN)6] was dried by heating powdered K4[Fe(CN)6]x3H2O in a vacuum of 1 mbar to 80 C. for at least 24 hours.) After 16 hours, the reaction mixture was cooled to room temperature. Conversion and yield were determinable by means of gas chromatography. An isolation of the product took place according to the customary workup (distillation, crystallization or chromatography).
Reference: [1] Patent: US2009/62541, 2009, A1, . Location in patent: Page/Page column 4
[2] Patent: US2009/62541, 2009, A1, . Location in patent: Page/Page column 4
[3] New Journal of Chemistry, 2012, vol. 36, # 11, p. 2334 - 2339
[4] Synlett, 2007, # 4, p. 555 - 558
[5] Synthesis, 2008, # 20, p. 3351 - 3355
  • 3
  • [ 17180-94-8 ]
  • [ 557-21-1 ]
  • [ 40805-79-6 ]
YieldReaction ConditionsOperation in experiment
60% With dmap; 1,1'-bis-(diphenylphosphino)ferrocene; nickel(II) chloride hexahydrate; zinc In acetonitrile at 80℃; for 4 h; Inert atmosphere; Sealed tube General procedure: Under argon protection, NiCl2·6H2O (0.05mmo 1,11.9mg), dppf (0.06mmol, 33.3mg), Ζn (0·2mmol, 13.0mg), DMAP (1.0mmol, 122.2mg), Ζn(CN)2 (0.8mmol) , 93.9mg),p-Chloroanisole (1.0 mmol, 140.6 mg) and acetonitrile (5.0 mL) were sequentially added in a 25.0 mL sealed tube, then directly put it into the oil bath at 60 °C, and heating was stopped after 6h, and cooled to room temperature, the reaction solution was directly filtered through a short silica gel column, washed with dichloromethane, concentrated and purified by silica gel column chromatography( given that the product is most easily pulled out, in order to avoid loss of sample mix, unless otherwise noted, both are wet method). Eluent: petroleum ether / ethyl acetate = 20:1, the product was 117.2 mg as a white solid, yield 88percent, and 1H NMR purity was greater than 98percent.
Reference: [1] Organic Letters, 2017, vol. 19, # 8, p. 2118 - 2121
[2] Patent: CN108623495, 2018, A, . Location in patent: Paragraph 0043; 0045; 0189-0191
  • 4
  • [ 4595-59-9 ]
  • [ 40805-79-6 ]
Reference: [1] Chemistry - A European Journal, 2007, vol. 13, # 21, p. 6249 - 6254
  • 5
  • [ 4595-59-9 ]
  • [ 40805-79-6 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 5, p. 1709 - 1716
  • 6
  • [ 4595-59-9 ]
  • [ 40805-79-6 ]
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 9, p. 4922 - 4931
  • 7
  • [ 40929-50-8 ]
  • [ 40805-79-6 ]
Reference: [1] Patent: WO2012/129564, 2012, A2,
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 10, p. 3783 - 3805
[3] Journal of Organic Chemistry, 2015, vol. 80, # 5, p. 2676 - 2699
[4] Patent: WO2009/148452, 2009, A1,
  • 8
  • [ 75-05-8 ]
  • [ 109299-78-7 ]
  • [ 40805-79-6 ]
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 38, p. 13246 - 13252
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 40805-79-6 ]

Nitriles

Chemical Structure| 1753-48-6

[ 1753-48-6 ]

2-Aminopyrimidine-5-carbonitrile

Similarity: 0.86

Chemical Structure| 16357-69-0

[ 16357-69-0 ]

4-Aminopyrimidine-5-carbonitrile

Similarity: 0.86

Chemical Structure| 1753-50-0

[ 1753-50-0 ]

2-Chloropyrimidine-5-carbonitrile

Similarity: 0.78

Chemical Structure| 4774-34-9

[ 4774-34-9 ]

4-Hydroxypyrimidine-5-carbonitrile

Similarity: 0.73

Chemical Structure| 17321-97-0

[ 17321-97-0 ]

2-Amino-4-methylpyrimidine-5-carbonitrile

Similarity: 0.72

Related Parent Nucleus of
[ 40805-79-6 ]

Pyrimidines

Chemical Structure| 1753-48-6

[ 1753-48-6 ]

2-Aminopyrimidine-5-carbonitrile

Similarity: 0.86

Chemical Structure| 16357-69-0

[ 16357-69-0 ]

4-Aminopyrimidine-5-carbonitrile

Similarity: 0.86

Chemical Structure| 2036-41-1

[ 2036-41-1 ]

5-Methylpyrimidine

Similarity: 0.81

Chemical Structure| 1753-50-0

[ 1753-50-0 ]

2-Chloropyrimidine-5-carbonitrile

Similarity: 0.78

Chemical Structure| 4774-34-9

[ 4774-34-9 ]

4-Hydroxypyrimidine-5-carbonitrile

Similarity: 0.73